Cargando…
Drug Delivery and Therapy Strategies for Osteoporosis Intervention
With the advent of the aging society, osteoporosis (OP) risk increases yearly. Currently, the clinical usage of anti-OP drugs is challenged by recurrent side effects and poor patient compliance, regardless of oral, intravenous, or subcutaneous administration. Properly using a drug delivery system or...
Autores principales: | Ma, Mingyang, Zeng, Huiling, Yang, Pei, Xu, Jiabing, Zhang, Xingwang, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534890/ https://www.ncbi.nlm.nih.gov/pubmed/37764428 http://dx.doi.org/10.3390/molecules28186652 |
Ejemplares similares
-
Drug delivery strategy in hepatocellular carcinoma therapy
por: Yang, Sisi, et al.
Publicado: (2022) -
The feasibility of oral targeted drug delivery: Gut immune to particulates?
por: Ren, Yuehong, et al.
Publicado: (2023) -
Delivery strategies for macromolecular drugs in cancer therapy
por: Guo, Qin, et al.
Publicado: (2020) -
Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?
por: Thurner, Gudrun C., et al.
Publicado: (2021) -
Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement
por: Ren, Yuehong, et al.
Publicado: (2022)